8/F, 35 QRC Building, No.35 Queens Road, Central, Hong Kong
  • Cyramza (Ramucirumab)

    ---Indications and Usage--- Cyramza is a human vascular endothelial growth factor receptor 2 (VEGFR2) antagonist indicated: (1) as a single agent or in...

    Lung CancerGastric CancerLiver CancerColorectal Cancer
  • Cabometyx (Cabozantinib)

    Cabozantinib, developed by Exelixis Biopharmaceuticals, USA, is a broad-spectrum anticancer drug with multiple targets, including MET, VEGFR1/2/3, ROS1...

    Lung CancerLiver CancerKidney CancerThyroid Cancer
  • Of 1Page2Record